cancer

Report details 'death with dignity' at U.S. cancer...
About three dozen demonstrators stand vigil outside the University of Washington Medical Center in protest of the Death with Dignity Act on March 5, 2010, in Seattle. (AP file photo)
Forty terminal cancer patients received lethal prescriptions for death with dignity at a cancer center in Seattle in 2009-2011, according to a report published in the April 11...
Scientists find new gene markers for cancer risk
NEW YORK--A huge international effort involving more than 100 institutions and genetic tests on 200,000 people has uncovered dozens of signposts in DNA that can help reveal...
Clinical study to focus on cancer stem cells
The Asahi Shimbun
Japan's first clinical study to focus on attacking cancer stem cells, which can cause relapses and spread of the disease, will start in early April at the National Cancer...
Residents concerned on effects of thyroid doses in...
The Asahi Shimbun
Although studies have shown that most local residents were likely not exposed to cancer-causing doses of radiation from the crippled Fukushima nuclear plant, the great fear...
WHO: Small cancer risk after Fukushima accident
A girl undergoes an ultrasound thyroid gland test at the Tokai Village Hospital in Ibaraki Prefecture on Nov. 5, 2012. (Asahi Shimbun file photo)
LONDON--People exposed to the highest doses of radiation during the Fukushima nuclear plant accident in 2011 may have a slightly higher risk of cancer that is so small it...
SKorea says Samsung chip plant caused cancer
Samsung group companies' head offices in Seoul in May 2010 (Asahi Shimbun file photo)
SEOUL, South Korea--A South Korean government agency said Dec. 14 that working at a Samsung Electronics factory caused the breast cancer of a worker who died earlier this year, ...
Study finds painkillers work, or not, according to...
Scientists have found a genetic basis for why painkillers have a stronger effect on some people than others, a discovery that could help physicians prescribe analgesics more...
Possible solution found for cancer obstacle in stem ...
iPS cells (Provided by University of Kyoto)
Japanese scientists said they have developed a possible remedy for a major obstacle in developing regenerative therapies that use artificial body cells derived from pluripotent ...
Thyroid gland tests on kids in Nagasaki to be...
Children lining up to drink cups of potassium iodide, which prevents thyroid cancer, at an evacuation center in Kawamata, Fukushima Prefecture, on March 12, 2011 (Asahi Shimbun file photo)
The Environment Ministry has begun thyroid gland tests on children in faraway Nagasaki Prefecture as part of efforts to gauge the effects of radiation fallout from last year's...
Kabuki legend Danjuro basks in the spotlight after...
Ichikawa Danjuro XII (Photo by Makoto Kaku)
More than eight years ago, famed kabuki actor Ichikawa Danjuro XII was diagnosed with acute premyelocytic leukemia as he was performing a well-known kabuki play.
BIZ BRIEF: Chugai gains new insight into cancer...
Chugai Pharmaceutical Co. announced Oct. 19 a major step forward in understanding recurrence and metastasis in cancer, as well as how cancer cells become resistant to drugs.
Nobel laureate Yamanaka: I'll supply premium iPS...
Shinya Yamanaka discusses the need for clinically viable iPS cells, during an interview in Kyoto's Sakyo Ward, Oct. 11. (Kazunori Takahashi)
KYOTO--Nobel laureate Shinya Yamanaka has said he will begin supplying high-quality induced pluripotent stem (iPS) cells to external research institutions from early next year...
Fukushima residents failing to complete...
A child undergoes an external radiation exposure test at an evacuation shelter in Fukushima city, Fukushima Prefecture, on March 15, 2011. (Asahi Shimbun file photo)
Critical data is missing for two-thirds of children tested for thyroid problems in Fukushima Prefecture, because their families have failed to declare the children's...
Tough cancer 'shields' to be targeted with antibody ...
The Asahi Shimbun
Researchers will launch clinical trials, the first of their kind, on a cancer immunotherapy that aims to remove healthy cells that end up shielding a tumor.
BIZ BRIEF: Medivation, Astellas say XTANDI capsules ...
Medivation Inc. and Astellas Pharma Inc. on Sept. 13 announced the availability of XTANDI (enzalutamide) capsules for patients in the United States with metastatic...
BIZ BRIEF: DSP files China license request for...
OSAKA—Dainippon Sumitomo Pharma Co. has applied to license its amrubicin HCI anti-cancer drug in China, the company said Sept. 5.
BIZ BRIEF: Sony to launch 'Cell Sorter' for cell...
Sony announced on June 11 that it will begin accepting orders for its Cell Sorter SH800 starting this fall, an instrument for cell analysis utilizing Blu-ray Disc technology,...
Behind the miso soup, a dying mother's love for her ...
Shingo and Hana Yasutake viewing the finished book's cover and pages at their home in Chuo Ward, Fukuoka (Tadashi Mizowaki)
FUKUOKA--Tears spilled from Chie Yasutake’s eyes when she was taken to a hospital, unable to stop her convulsions or end the relentless pain.
Fujifilm takes image analysis technology for lung...
Fujifilm Corp.'s diagnostic imaging system shows a computerized tomography image on the left and search results for similar symptoms on the right. (Provided by Fujifilm Holdings Corp.)
Fujifilm Corp. said April 10 it has developed the world's first system to help doctors identify lung cancer using artificial intelligence to analyze images of CT scans.
Researchers identify genes associated with lung...
Japanese researchers have discovered five genes that may be responsible for the onset of lung cancer, raising hope that drugs to treat the deadly disease could be developed.